NCT02004028 2024-02-20Window of Opportunity Study of VS-6063 (Defactinib) in Surgical Resectable Malignant Pleural Mesothelioma ParticipantsVerastem, Inc.Phase 2 Terminated35 enrolled 15 charts
NCT01549535 2016-11-25Polyp Detection With The Peerscope Systemâ„¢PeerMedical Ltd.Phase 2 Completed197 enrolled